Skip to main content

Peer Review reports

From: hENT1’s role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients

Original Submission
20 Nov 2022 Submitted Original manuscript
9 Dec 2022 Reviewed Reviewer Report
15 Jan 2023 Reviewed Reviewer Report - Satoshi Kobayashi
25 Jan 2023 Author responded Author comments - Xinyu Huang
Resubmission - Version 2
25 Jan 2023 Submitted Manuscript version 2
Publishing
3 Feb 2023 Editorially accepted
8 Feb 2023 Article published 10.1186/s12876-023-02666-x

You can find further information about peer review here.

Back to article page